BIVRX
Price
$17.13
Change
+$0.25 (+1.48%)
Updated
Feb 21 closing price
Net Assets
1.11B
QLENX
Price
$16.55
Change
-$0.13 (-0.78%)
Updated
Feb 21 closing price
Net Assets
2.85B
Ad is loading...

BIVRX vs QLENX

Header iconBIVRX vs QLENX Comparison
Open Charts BIVRX vs QLENXBanner chart's image
Invenomic Investor
Price$17.13
Change+$0.25 (+1.48%)
VolumeN/A
Net Assets1.11B
AQR Long-Short Equity N
Price$16.55
Change-$0.13 (-0.78%)
VolumeN/A
Net Assets2.85B
BIVRX vs QLENX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BIVRX vs. QLENX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIVRX is a Hold and QLENX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
QLENX has more cash in the bank: 2.85B vs. BIVRX (1.11B). QLENX pays higher dividends than BIVRX: QLENX (18.52) vs BIVRX (2.36). BIVRX was incepted earlier than QLENX: BIVRX (8 years) vs QLENX (12 years). BIVRX is a more actively managed with annual turnover of: 140.00 vs. QLENX (0.00). QLENX has a lower initial minimum investment than BIVRX: QLENX (2500) vs BIVRX (5000). QLENX annual gain was more profitable for investors over the last year : 28.94 vs. BIVRX (0.86). QLENX return over 5 years is better than : 119.29 vs. BIVRX (74.39).
BIVRXQLENXBIVRX / QLENX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years12 years-
Gain YTD1.0026.15816%
Front LoadN/AN/A-
Min. Initial Investment50002500200%
Min. Initial Investment IRAN/AN/A-
Net Assets1.11B2.85B39%
Annual Yield % from dividends2.3618.5213%
Returns for 1 year0.8628.943%
Returns for 3 years-15.7270.77-22%
Returns for 5 years74.39119.2962%
Returns for 10 yearsN/A129.41-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVRI13.810.01
+0.07%
Everi Holdings
YETI36.83-0.08
-0.22%
YETI Holdings
GNFT3.83-0.09
-2.30%
Genfit SA
CTXR1.80-0.05
-2.70%
Citius Pharmaceuticals Inc
AER101.67-4.11
-3.89%
Aercap Holdings NV